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Aim: To evaluate a feeding regimen routinely providing > 180 ml/kg/d fortified human milk 
to very preterm infants and impact on in-hospital growth, osteopenia and neurodevelopment.  
Method: Retrospective population-based descriptive study of infants < 30 weeks gestation 
admitted within 24 h of birth and discharged during the six-year period 2005 to 2010. Growth 
and neurodevelopment was assessed until two years corrected age, and cerebral palsy up to 4 
years corrected age 
Results: Ninety-nine infants below 30 weeks gestation were admitted within 24 h of birth 
during the six-year period, of which 84 (85%) survived to discharge. Two infants had surgical 
necrotizing eneterocolitis, both survived to two years follow up. Seventy-eight infants (mean 
27 weeks) had complete growth data until discharge. Full enteral feeds were tolerated after 
mean 10 days. Average milk volumes were 193 ml/kg/d from 15-42 days of life. Rates of 
weight below 10th centile were 10% at birth and 14% at discharge. Head circumference Z-
scores were stable from birth to discharge. Blood values did not indicate osteopenia. 
Increasing head circumference Z-scores were associated with improved language 
development.  
Conclusion: This high enteral feeding volume regimen was associated with low rates of in-
hospital growth restriction and good head growth. High enteral volume intake seems safe and 
may improve nutritional status of very preterm infants. 
  







In very preterm infants in-hospital growth restriction is still common (1, 2). Early life 
malnutrition and poor in-hospital growth is associated with increased risk of retinopathy, 
osteopenia and later impaired long-term growth and neurodevelopment (3-5). It is therefore 
essential to improve nutrition of preterm infants in order to reduce the negative impact of poor 
nutrition on growth and later neurodevelopment (6).  
 It is rarely possible to provide enough enteral nutrition to cover nutritional needs for 
very preterm infants during the first seven to fourteen days of life. Recent guidelines and 
expert recommendations thus strongly emphasize the importance of early adequate parenteral 
nutrition (7-9). There has been less focus on how to optimize the enteral nutrition after these 
infants have achieved full enteral tolerance and entered a stable growing phase. Guidelines 
recommend an enteral protein intake of 4.0-4.5 g/kg/d for the healthy growing preterm infant. 
It is suggested that enteral feeding volumes of 150-180 ml/kg/d, using formula or fortified 
breast milk, are likely to meet these requirements (10). In a recent large international survey 
on enteral feeding practice in very preterm infants the majority of neonatal units aimed for 
enteral feeding volumes of 160-180 ml/kg/d using fortified human milk or preterm formula, 
and only 9 % of surveyed units aimed for higher feeding volumes (11).   
 The main objective of this study was to evaluate a feeding regimen routinely targeting 
a daily enteral feeding volume > 180 ml/kg/d to very preterm infants and its effect on in-
hospital growth. Secondly, we evaluated possible biochemical markers of osteopenia of 
prematurity during hospitalization and the association between in-hospital growth and 








PATIENT AND METHODS 
Setting and study design 
All infants with gestational age (GA) < 30 weeks born in the two northernmost counties in 
Norway are treated in the tertiary neonatal unit at the University Hospital of North Norway 
(12). In this population-based, retrospective and descriptive study, we included all very 
preterm infants born before 30 weeks gestation, admitted within 24 h of birth and discharged 
during the six-year period January 2005 to December 2010.   
 
Feeding policy  
The feeding policy in the neonatal unit remained unchanged during the six-year period. 
Intravenous amino acids were commenced from first day of life (DOL 1) with 0.5-1.0 g/kg/d 
and gradually increased to 3.5 g/kg/d on DOL 3-5. Intravenous lipids were increased to 2 
g/kg/d on DOL 4-5. Concomitantly enteral nutrition was initiated early, usually on DOL 1. 
Enteral feeds were gradually increased using continuous gastric drip for the first seven to 
fourteen days (13). The infants were primarily fed mothers own raw milk. If this was not 
available, we used unpasteurized donor human milk from the unit’s milk bank. Formula was 
rarely used except under special circumstances when there was a lack of donor milk. For 
infants older than seven to ten days of age tolerating full feeds (≥ 150 ml/kg/d) we added a 
multinutrient human milk fortifier (Nutriprem®, Nutricia, Schipol, The Netherlands) 
providing 0.8 g extra protein per 100 ml breast milk. We routinely continued fortification until 
the infant reached a body weight of around 2500 g, and we did not adjust the amount of breast 
milk fortification. The prescribed enteral feeding volume during the “stable growth phase” 
was adjusted between 170-220 ml/kg/d aiming to achieve optimal weight gain (15-20 g/kg/d) 






Clinical data, measurements and follow-up 
We collected clinical data from medical records. Initial illness severity was assessed using 
Clinical risk index babies 2nd version score (CRIB2). Verified necrotizing enterocolitis (NEC) 
was diagnosed according to Bell stage 2-3 (14). Bronchopulmonary dysplasia (BPD) was 
defined as need for oxygen or respiratory support at postmenstrual age (PMA) 36 weeks. We 
collected data on nutrition including duration of parenteral nutrition, onset of enteral nutrition 
and age (in days) at full enteral tolerance, defined as 150 ml/kg/d. A previous audit in our 
neonatal unit showed that most very preterm infants tolerated full enteral feeds within ten to 
fourteen days of age, in line with findings from other Norwegian units (11). We therefore 
defined DOL 15-49 (week 3-7) as a “stable growth phase”. During this period we calculated 
the average daily enteral volume intake for infants tolerating full enteral feeds (≥ 150 ml/kg/d) 
on at least 6 out of 7 days, and present these data for DOL 15-49 (week 3-7). We excluded 
weeks where infants had not yet achieved full feeds or weeks with intercurrent illness 
episodes making them too sick to tolerate full enteral feeds. Thus, the presented intake values 
are data from infants on full feeds in a stable growth phase, reflecting enteral volume 
tolerance. Weight was assessed daily for the first two to three weeks and then every second to 
third day until discharge. Weight and height was also recorded on follow-up until two years 
corrected age.  
 Data on weight and head circumference (HC) from birth to discharge were converted 
to standard deviation (SD; Z) scores using the 2013 Fenton growth chart (15). The Fenton 
chart does not estimate HC Z-score for infants < 24.0 weeks gestation and we decided to use 
the Z-scores for 24.0 weeks gestation for all five infants with GA between 23.0-23.6 weeks. 
Data on length from birth to discharge was not reported due to the poor reliability of length 
measurement in the routine neonatal intensive care and many missing values. Small for 





growth we calculated difference in Z-score for weight and HC from birth to discharge. Weight 
and body mass index at one and two year corrected age was assessed using the WHO growth 
chart as reference for Z-scores (16). 
 Biochemical markers suggested indicating osteopenia of prematurity (alkaline 
phosphatase, phosphate and ionized calcium) were measured from around two weeks of age 
and thereafter weekly during the study period. We report these results for three separate 
periods; DOL 15-28, DOL 29-42 and DOL 43-56. We averaged the values if several blood 
tests were taken within these periods. Hyperphosphatasia, hypophosphatemia or hypocalcemia 
were defined as alkaline phosphatase (ALP) > 800 U/L, serum phosphate <1.4 mmol/L and 
serum ionized calcium < 1.10 mmol/L, respectively. 
 Most infants were included in our routine follow-up program at one and two years 
corrected age with assessment of growth, neurological examination by a pediatrician and 
motor assessment by a physiotherapist. Bayley III (BSID-III) neurodevelopmental assessment 
including total cognitive and language scores, but not motor score, was performed at two 
years corrected age.  
 
Statistical analysis 
Data were analysed using IBM-SPSS statistical software version 23 (IBM, New York, USA). 
Normally distributed interval data are displayed using mean and standard deviation (SD), and 
non-normally distributed data are displayed using median and interquartile range (IQR). 
Categorical data are displayed as frequency (%). We used the chi square test for categorical 
data and the T-test or Mann-Whitney U test for interval data. A multiple regression model was 
used to analyze associations between in-hospital growth and neurodevelopment. We included 
five possible predictors for neurodevelopment; sex, BPD, SGA at birth and Z-score changes 









The regional ethical committee of Northern-Norway approved this study. 
 
RESULTS 
Ninety-nine infants below 30 weeks gestation were admitted within 24 h of birth during the 
six-year period, of which 84 (85%) survived to discharge. The fifteen infants who died were 
significantly more immature (mean GA 24.9 vs 27.3 weeks), had lower Apgar values (mean 
5.1 vs 7.5) and higher initial illness severity (mean CRIB2 score 13.3 vs 9.2) than those who 
survived. Both infants with NEC were surgically treated and both survived to follow-up at 
two years corrected age. Six infants with mean GA 28 weeks and mean birth weight 1100 g 
were transferred to other neonatal units prior to 34 weeks PMA, and were not included in our 
follow-up.  
 The core population of this study was therefore 78 infants with mean GA 27 weeks 
(Table 1). The average enteral daily volume intake from third to seventh week of life is shown 
in Figure 1. From the third to the sixth week of life most infants received between 190-200 
ml/kg/d, provided full enteral tolerance. Thereafter the enteral volume was gradually reduced, 
but on average kept around 180 ml/kg/d until the seventh week of life. Data on growth and 
nutrition, from birth and up to two years corrected age for all infants in this population based-
study, are shown in Table 1 and Figure 2a-b. The proportion of infants classified as SGA was: 
at birth 10%, at PMA 34 weeks 17% and at discharge (median 39 weeks) 14%. The mean Z-
score for weight decreased from -0.16 at birth to -0.48 at discharge. The mean Z-score for HC 





 Compared with infants born at 28-29 weeks gestation, infants born before 28 weeks 
gestation tolerated full feeds later, received longer parenteral nutrition and had higher rates of 
BPD (Table 1). The more immature infants were discharged later and had correspondingly 
higher weight at discharge. The immature infants (< 28 weeks gestation) seemed to have more 
catch-up growth during the last weeks of admission, reflected by a decrease in the proportion 
of infants with weight < 10th centile from 18% at 34 weeks to 12% at discharge. 
 Growth data were missing for six and fifteen children at one and two years corrected 
age, respectively. The Z-scores for weight at discharge and the Z-score changes between birth 
and discharge were similar between those missing data and those with complete follow-up 
weight data until two years corrected age. Overall, the Z-scores for weight were stable for the 
whole study population from discharge and until two years corrected age (Table 3, Figure 2a).  
 The mean serum values for ALP, phosphate and ionized calcium were within normal 
limits for the majority of all infants (Table 2). There were five, three and no infant with ALP 
> 800 U/L during first (DOL 15-28), second (DOL 29-42) and third (DOL 43-56) period, 
respectively. No infants had ALP > 900 U/L. There were six infants in the first period with 
hypophosphatemia (1.07-1.35 mmol/L). During the second and third period, no infants had 
hypophosphatemia. Infants with phosphate < 1.8 mmol/L had significantly higher ALP levels 
in the first period compared to those with phosphate ≥ 1.8 mmol/L (mean 560 vs 380 U/L, p 
0.029). During the second and third period, there was no correlation between ALP and 
phosphate levels. One patient in the first period, one in the second period and no patients in 
the third period had hypocalcemia. 
 Seven of 78 (9.0%) infants developed cerebral palsy up to four years of age. Four out 
of five infants diagnosed with mild cerebral palsy (gross motor function classification scale-
GMFCS-1-3) were diagnosed after two years of age. BSID-III cognitive and language scores 





respective Z-score changes between birth and discharge, were similar between those missing 
(n=24) and those with BSID-III data (n= 54) available. For all 54 infants the mean (SD) 
cognitive index was 95.7 (8.8) and the mean (SD) language index was 94.4 (12.1). Three 
children (5.5 %) had cognitive score index < 85 and nine children (17%) had language score 
index < 85. In the unadjusted linear regression analysis, Z-score changes in HC and female 
sex were both associated with improved language score (Figure 3, Table 3). In the stepwise 
multiple regression models only Z-score changes in HC remained significant (Table 3). We 
did not find any other associations between Z-score for birth weight and HC or in-hospital 





In this population-based observational study of very preterm infants born before 30 weeks 
gestation we found that the proportion of infants growth restricted at discharge (14%) was 
similar to those who were SGA at birth (10%). Median age at discharge was 39 weeks with a 
body weight around 3 kg, and the Z-scores for weight at discharge were within normal limit 
for most infants. Follow-up at one and two years corrected age showed a stable growth pattern 
along the same Z-scores for weight and body mass index.  
 
Many recent studies from the USA and Europe still report high prevalence of in-hospital 
growth restriction in very preterm infants (1, 2, 17). There are some exceptions. Graziano and 
co-workers introduced an improved “feeding bundle” in their unit, and reported in a cohort of 
very preterm infants that 19% were growth restricted at discharge and Z-scores for weight at 
discharge were similar to the findings in our study (18). In their study, with slightly more 
mature infants, time to full enteral feeds was much longer (18-21 days), milk fortification 





study. A retrospective study from Germany, with a similar population of preterm infants than 
in our study, reported only eight days to full enteral feeds and a low rate of in-hospital growth 
restriction (19). However, in both the German study (19) and a recent study from the USA 
(20) the use of fortified human milk compared to preterm formula was associated with lower 
weight gain among preterm infants. In our study, fortified human milk was exclusively used 
up to 34 weeks gestation and for most infants until discharge, and growth was still good. 
 The main difference between our study and many other reports on enteral nutrition to 
preterm infants is the high enteral volume intake (18, 21). For our cohort of infants with a 
mean birth weight < 1000 g the recommend enteral protein intake is 4.0-4.5 g/kg/d (10). After 
the first four weeks of lactation, the protein content of expressed preterm milk declines to 
around 1.2 g/100 ml (22). During the study period we used a human milk fortifier increasing 
protein content by 0.8 g/100 ml breast milk, but more current commercial human milk 
fortifiers increases protein content by 1.0-1.4 g/100 ml (23). Still, an enteral volume of 180 
(160-200) ml/kg/d is required to achieve a protein intake of 4.0-4.5 g/kg/d. It is also a clinical 
perception that not all preterm infants tolerate full strength fortification. Increasing enteral 
fluid volume is then an alternative in order to increase protein and energy delivery. The 
parenteral nutrition regimen in our unit has been slightly modified since 2011. However, an 
“aggressive approach” with early very high amino acid and lipid delivery may have early and 
prolonged side effects (24-26). We believe it is safer to focus on achieving early full enteral 
tolerance and optimize enteral nutrition in the stable growth phase. An adequate protein intake 
is the major driving force of growth in preterm infants (27). Early enteral protein intake is 
positively associated with neurodevelopmental outcome (21). However, recent data indicate 
that there may be a ceiling effect of enteral protein supply (23). We still believe that low daily 
enteral volumes often leads to an intake of protein below the recommended range which may 





 In Scandinavia, enteral breast milk feeding is usually commenced early and increased 
relatively fast, and the prevalence of NEC among extremely low birth weight infants is around 
5-6% (28, 29). In our study, infants < 30 weeks gestation tolerated 150 ml/kg/d at a median 
age of ten days and only two children developed NEC, both surviving to discharge. 
Systematic review data suggest that advancing enteral feed volumes at daily increments of 30-
40 ml/kg (compared to 15-24 ml/kg) does not increase the risk of NEC or death in very low 
birth weight infants (30). Large fluid volumes may be difficult to handle for some preterm 
infants, in particular those with BPD. However, fluid restriction may lead to energy deficiency 
and can negatively impact postnatal growth (31). A careful balance of fluid and energy supply 
is crucial.  
 Infants provided high enteral feeding volumes of fortified breast milk experienced a 
modest decrease in Z-scores for weight (-0.3), but no changes in Z-score for HC from birth to 
discharge. Better head growth than overall weight gain in human milk fed very preterm 
infants is consistent with the previously reported “breastfeeding paradox” that also describes 
better neurodevelopmental outcome in human milk fed infants in spite of suboptimal initial 
weight gain (20).  
 In our study most blood values suggested as “biochemical markers of osteopenia of 
prematurity” were normal or normalised without any specific intervention. In one study the 
combination of ALP > 900 U/L and phosphate < 1.8 mmol/L detected lower bone mineral 
density with a sensitivity of 100% and a specificity of 70% (32). No infants had ALP > 900 
U/L and there was no correlation between phosphate < 1.8 mmol/l and ALP values after the 
fourth week of life. Osteopenia of prematurity is a radiological diagnosis, but a major loss of 
bone mineralization has to occur before radiological changes are visible. We did not diagnose 
any infant with osteopenia of prematurity during the study period, but no routine screening 





and phosphate combined with low rates of growth restriction may thus indicate that infants 
received sufficient minerals and nutrition for bone growth. Currently, there is insufficient 
evidence that any blood values are valid as early biochemical markers of osteopenia in 
preterm infants (4).  
 Relatively few studies report neurodevelopmental outcome of feeding regimens (3, 6), 
but recent recommendations suggest this to be mandatory when reporting neonatal nutrition 
and growth outcomes (22). In our study, the majority of infants had cognitive and language 
score above -1 SD. In an explorative statistical analysis, we found an association between 
increasing Z-scores of HC and positive language scores. This finding need cautious 
interpretation due to small numbers and no prospective predefined selection of statistical 
analyses.  
 This study has strengths, but also inherent limitations associated with a retrospective 
single-center observational study. First, we have analyzed an unselected population-based 
cohort but the small sample size limits statistical power to detect differences in outcomes after 
subgroup comparisons. Second, body weight is only a proxy of growth and protein accretion. 
The infants in our cohort had low rates of postnatal growth restriction, but investigations with 
air displacement plethysmography or dual-energy X-ray absorptiometry scan would have 
revealed better data on body composition (22). Third, we did not have consistent data on head 
circumference during follow-up after discharge and no data on parental socioeconomic status, 
both parameters that may affect neurodevelopmental outcome. Fourth, we did not have a 
control group and other factors than the feeding regimen may contribute to the good growth 
observed. Finally, the incomplete data on neurodevelopment assessment limits the power to 
detect differences depending on growth. However, our data shows that it is possible to achieve 
satisfactory in-hospital growth in a population of very preterm infants with corresponding 






In this retrospective study a feeding regimen routinely providing > 180 ml/kg/d fortified 
human milk to very preterm infants was associated with low rates of in-hospital growth 
restriction and good head growth. Potential benefits or harm of providing high enteral feeding 
volumes to clinically stable preterm infants after 2 weeks of life should be tested in a large 
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GA 28-29 weeks 
 
n=29 




Gestational age (weeks), mean (SD)  
 
27.2 (1.5) 28.7 (0.5) 26.3 (1.1)  
Birth weight (gram), mean (SD)  
 
943 (231) 1089 (248) 857 (170)  
Z-score, birth weight, mean (SD) 
 
-0.16 (0.79) -0.29 (0.82) -0.09 (0.77) 0.30 
SGA at birth (%) 
 
8 (10) 4 (14) 4 (8) 0.50 
Z-score, HC at birth, mean (SD) 
 
0.32 (1.02) 0.13 (1.14) 0.44 (0.93) 0.21 
Male (%) 
 
47 (60) 17 (59) 30 (61) 0.82 
Onset enteral nutrition 0-24 h (%) 
 
63 (81) 24 (83) 39 (80) 0.85 
Day of life full feeds (150 ml/kg), median 
(IQR) 
 
10 (7-14) 7.5 (6-12) 11 (8-15) 0.024 
Days parenteral nutrition, median (IQR) 
   
8 (5-13) 6 (2-11.5) 9 (6-14) 0.013 
Bronchopulmonary dysplasia (%) 
 
31 (40) 6 (21) 25 (51) 0.009 
Necrotising enterocolitis (%) 
 
2 (2.6) 0 (0) 2 (4.1) 0.27 
Weight (gram), 34 weeks PMA, mean (SD)  
 
1999 (319) 1973 (343) 2015 (307) 0.58 
Z-score, weight  34 weeks PMA, mean (SD) 
 
-0.50 (0.79) -0.57 (0.86) -0.47 (0.75) 0.60 
SGA at 34 weeks PMA (%) 
 
13 (17) 4 (14)  9 (18) 0.60 
PMA in weeks at discharge, median (IQR)  
 
39 (37-41) 37 (36-40) 39 (37-42) 
 
0.01 










Z-score, weight at discharge, mean (SD) 
 
 











5 (17) 6 (12) 0.63 
Z-score, HC at discharge, mean (SD) 
 
0.35 (0.90) 0.48 (0.81) 0.27 (0.95) 0.34 
Z-score, weight 1 year CA, mean (SD)  -0.47 (1.19) -0.52 (1.50) -0.44 (0.96) 0.78 
 

































BMI; Body mass index, CA; corrected age, GA; gestational age, HC; head circumference, IQR; 
interquartile range, PMA; postmenstrual age, SD; standard deviation, SGA; small for gestational age < 






Table 2: Metabolic markers suggested indicating osteopenia 
 
 
 DOL 15-28 DOL 29-42 DOL 43-56 
Serum alkaline phosphatase, U/L   452 (159) 405 (154) 362 (129) 
Serum phosphate, mmol/L 2.07 (0.36) 2.11 (0.25) 2.09 (0.23) 
Serum ionized calcium, mmol/L 1.37 (0.08) 1.38 (0.07) 1.38 (0.05) 
 
DOL; day of life.  





Table 3: Neurodevelopment at 2 years corrected age - growth and clinical variables 
 
 






















-2.20 to 11.91 
      








3.61 0.03 to 7.19 
 
∆ Z-score 






-5.51 to 3.28 
 
∆ Z-score 






-9.63 to 1.79 













-10.48 to 10.39 
 
 






















-6.20 to 13.25 
      








1.30 -4.61 to 7.21 
 
∆ Z-score 






4.65 to 1.73 
 
∆ Z-score 






-9.53 to  6.22 












-12.75 to 16.12 
 
BPD; bronchopulmonary dysplasia, BSID-III, Bayley Scales of Infant and Toddler Development, 
Third Edition; HC; head circumference, SGA; small for gestational age < 10th centile. 









Figure 1  
Average enteral daily volume intake from third to seventh week of life in infants tolerating 








Figure 2 a 
Z-score weight and body mass index (BMI). From birth to discharge (n=78) and at 1 year (n = 










Figure 2 b 









Correlation between change in Z-score head circumference from birth to discharge and total 
language score  
 
 
